LIDODERM

Product NDC: 50436-1331
11-digit product format: 504361331
Labeler code: 50436
Product ID: 50436-1331_d61820f8-f0bb-4fa8-bd50-719070081acc
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lidocaine
Dosage form: PATCH
Route: CUTANEOUS
Labeler: Unit Dose Services
Application: NDA020612
Marketing category: NDA
Marketing start: 1999-03-20
Marketing end: 0000-00-00
Substance: LIDOCAINE
Active strength: 50 mg/g
Pharmacologic classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	50436-1331		I	Inactivated by FDA		2026-08-07
excluded package	package	50436-1331	50436-1331-1	I	Inactivated by FDA		2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50436-1331-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50436-1331-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50436-1331-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50436-1331-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50436-1331-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50436-1331-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50436-1331-1	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50436-1331-1	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50436-1331-1	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50436-1331-1	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50436-1331-1	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50436-1331-1	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50436-1331-1	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50436-1331-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50436-1331-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	50436-1331-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	50436-1331-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	50436-1331-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	50436-1331-1	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	50436-1331-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	50436-1331-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	50436-1331-1	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020612-001	LIDODERM	LIDOCAINE	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N020612-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N020612-001	LIDODERM	5%	PATCH / TOPICAL	AB	RLD, RS	1999-03-19	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020612-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020612-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020612-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020612-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020612-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020612-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020612-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020612-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020612-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020612-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020612-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020612-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020612-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020612-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020612-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020612-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020612-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020612-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020612-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020612-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020612-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020612-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020612-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020612-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020612-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020612-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020612-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020612-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020612-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020612-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020612-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020612-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020612-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020612-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020612-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020612-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020612-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020612-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020612-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N020612-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50436-1331-1	2020-01-31	C162847	48780-1	9d75b9cf-ec15-f424-e053-dadaa90a57ce	LIDODERM® (Lidocaine Patch 5%)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50436-1331-1	LIDODERM	30 g in 1 PATCH	PATCH	30		5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50436-1331-1	EA - Each	50436-1331	cd6934b2-0768-4dd1-b282-42ce75442c59	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LIDOCAINE	ACTIVE INGREDIENT	98PI200987	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
TARTARIC ACID	INACTIVE INGREDIENT	W4888I119H	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1
UREA	INACTIVE INGREDIENT	8W8T17847W	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50436-1331	LIDODERM (LIDOCAINE) PATCH [UNIT DOSE SERVICES]	5	Legacy NDC, 1 package rows	20180101_d499efc5-8bc3-4dbc-9d85-fae57dd9263c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine	LIDOCAINE	St. Mary's Medical Park Pharmacy	9dc3059c-3a3d-5810-e053-2a95a90ab0ba	2026-06-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Golden State Medical Supply, Inc.	0bef12dd-6cea-d12b-e063-6394a90a002e	2026-06-18	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Par Health USA, LLC	2ce8a4fe-8aa6-4dc5-ad0f-3984ae68c4bc	2026-05-27	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Preferred Pharmaceuticals Inc.	323e0ec2-c2e5-47d1-a39f-69ff5c99e324	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
LIDOCAINE	LIDOCAINE	DIRECT RX	a575bcb8-478f-1f7e-e053-2995a90a4b12	2026-03-17	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Sportpharm LLC	4611f0da-a41d-4861-9dd6-f16f1b007d33	2026-02-23	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	PHOENIX RX LLC	3c69e03c-e176-2c23-e063-6394a90aa41f	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	REMEDYREPACK INC.	0748b9e3-1247-4eeb-8158-3d641b2ad85d	2025-10-14	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	A-S Medication Solutions	e23a92e6-3445-4ba7-9ad2-86a3eec1717e	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Cardinal Health 107, LLC	fa69dfdf-ab73-48a9-944d-25e88d7766df	2025-06-05	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	REMEDYREPACK INC.	94ab1b99-e203-4a14-b852-42d3b37999c3	2025-02-14	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Asclemed USA, Inc.	f7ada189-7463-4bc7-83e7-f140558ecacf	2024-12-25	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Quality Care Products LLC	f20ab860-e49a-4f3f-868e-6a60780af5a7	2024-12-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Advanced Rx Pharmacy of Tennessee, LLC	1b561cc6-1d36-e259-e063-6294a90aacbd	2024-06-27	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
Lidocaine	LIDOCAINE	Bryant Ranch Prepack	65cf652c-87f2-43c6-a6f8-e4a83b42ce78	2024-01-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612
LIDODERM	LIDOCAINE PATCH 5%	TPU Pharma, Inc.	db0092f5-02a0-4076-ac32-969f075a6ab1	2022-12-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020612 application number: NDA020612

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
98PI200987	LIDOCAINE	137-58-6	LIDOCAINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1745091	lidocaine 5 % Medicated Patch	PSN	d499efc5-8bc3-4dbc-9d85-fae57dd9263c	5
1011705	Lidoderm 5 % Medicated Patch	PSN	d499efc5-8bc3-4dbc-9d85-fae57dd9263c	5
1011705	lidocaine 0.05 MG/MG Medicated Patch [Lidoderm]	SBD	d499efc5-8bc3-4dbc-9d85-fae57dd9263c	5
1745091	lidocaine 0.05 MG/MG Medicated Patch	SCD	d499efc5-8bc3-4dbc-9d85-fae57dd9263c	5
1745091	lidocaine 5 % Medicated Patch	SY	d499efc5-8bc3-4dbc-9d85-fae57dd9263c	5
1011705	Lidoderm 0.05 MG/MG Medicated Patch	SY	d499efc5-8bc3-4dbc-9d85-fae57dd9263c	5
1011705	Lidoderm 5 % Medicated Patch	SY	d499efc5-8bc3-4dbc-9d85-fae57dd9263c	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
50436-1331-1	50436133101	30 g in 1 PATCH	30 g	Historical